Trailing-twelve-month (TTM) revenue is $10.54 Billion with a year-over-year growth of +32.57%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $2,308,300,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-31 | $2,487,800,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-17 |
| Q1 FY2026Period ended 2026-03-31 | $2,709,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-30 | $3,035,700,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $10,540,800,000 |
Current P/S: $242,931,559,673 market capitalization ÷ $10,540,800,000 TTM revenue = 23.05x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $3.04B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:03.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Product | $1.8B | $2.4B | $3.7B | $5.0B | $5.9B | $7.6B |
| Service | $487M | $570M | $665M | $831M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Americas | $1.8B | $2.2B | $3.5B | $4.7B | $5.7B | $7.1B |
| Asia Pacific | $219M | $305M | $389M | $538M |
$10.54B
$10.54 Billion
+32.57%
vs. $7.95B a year ago (TTM)
+32.02%
5 Year compound annual growth rate
1 Year
+32.57%
3 Year
+26.05%
5 Year
+32.02%
10 Year
+26.90%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $9.01B | +$2.00B | +28.60% |
| 2024 | $7.00B | +$1.14B | +19.50% |
| 2023 | $5.86B | +$1.48B | +33.75% |
| 2022 | $4.38B | +$1.43B | +48.62% |
| 2021 | $2.95B | +$630.52M | +27.21% |
| 2020 |
TTM Growth
+32.57%
3-Year CAGR
+26.05%
5-Year CAGR
+32.02%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T20:00:03.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $1.1B |
| $1.4B |
| $813M |
| EMEA | $327M | $487M | $530M | $671M | $713M | $1.1B |
|---|
| $2.32B |
| ($93.19M) |
| (3.87%) |
| 2019 | $2.41B | +$259.34M | +12.05% |
| 2018 | $2.15B | +$505.18M | +30.69% |
| 2017 | $1.65B | +$517.02M | +45.79% |
| 2016 | $1.13B | +$291.58M | +34.81% |
